Geriatric Emergency Department Fall Injury Prevention Project

The purpose of this study is to assess whether certain Emergency Department patients at high risk of recurrent falls and injuries related to falls will benefit from the recommendations of the Center for Disease Control and Prevention's (CDC) Stopping Elderly Accidents, Deaths and Injuries program (STEADI Program).

Study subjects will be randomized to one of 3 arms: 1) current care; 2) a phone-based fall-prevention strategy; or 3) a home-visit fall prevention strategy

• Current emergency department care
• STEADI recommendations administered via phone at 14 days
• STEADI recommendations administered via a home visit at 14 days

The STEADI recommendations include the following:

• Follow-up with a primary care physician
• An assessment of your risk of falling. This includes looking at your ability to walk, your strength and balance.
• Assessment medications looking for potential medication interactions
• Measuring your vital signs (blood pressure and heart rate)
• Assessment of your vision
• Assessment of your footwear
• Recommendations to improve home safety (such as ensuring proper lighting, ensuring adequate hand-rails, and others)

Initial data collection will occur at the time of the ED visit. Intervention will occur 14 days after ED visit. Telephonic follow-up will occur at 3 months and 6 months after study enrollment.

Data will be collected from the patients/patient representatives and medical records. All data will be collected by trained research assistants (RAs)

Inclusion criteria

• Patients over the age of 65 with a ground level fall who live at home will be eligible for study inclusion

Exclusion criteria

• Being transferred from another facility, trauma activation, hospice or palliative care participant, end-stage heart failure (two or more congestive heart failure hospitalizations in past 6 months), end stage emphysema (two or more chronic obstructive pulmonary disease hospitalizations in past 6 months), metastatic cancer, severe leukemia or multiple myeloma or lymphoma on treatment or requiring transfusion and end stage renal disease requiring dialysis. An additional exclusion criterion is patients with dementia, if the subject is unable to state name or unable to point to an object (for those with aphasia)